<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03203694</url>
  </required_header>
  <id_info>
    <org_study_id>2008181</org_study_id>
    <nct_id>NCT03203694</nct_id>
  </id_info>
  <brief_title>Effects of Walking and Unilateral Leg Heating on Vascular Function in Diabetic Patients</brief_title>
  <official_title>Restoring Vasodilator Actions of Insulin in Patients With Type 2 Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Missouri-Columbia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Missouri-Columbia</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the present study is to determine the effects of increased walking and
      unilateral leg heating on leg vascular function in patients with type 2 diabetes (T2D).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The notion that habitual aerobic exercise increases insulin-induced vasodilation is largely
      founded on rodent studies, hence the urgent need for human studies, especially in patients
      with type 2 diabetes (T2D). For example, it remains unknown if increased walking, the most
      common form of physical activity, enhances skeletal muscle vasodilator actions of insulin in
      T2D. In addition, the molecular mechanisms by which exercise improves vasoreactivity to
      insulin have not been examined in humans. The investigators propose that in T2D patients who
      are sedentary (i.e., the vast majority), increased leg blood flow with walking or local
      heating signifies a vital strategy to correct vascular insulin resistance. This study will
      establish whether increased physical activity and associated hemodynamic forces (e.g., shear
      stress) are a direct form of vascular medicine in humans.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 1, 2018</start_date>
  <completion_date type="Anticipated">June 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Participants will be assigned to either a walking, unilateral leg heating, or no intervention for 8 weeks.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Vascular function</measure>
    <time_frame>Flow-mediated dilation will be measured at baseline and at 8 weeks following intervention</time_frame>
    <description>Flow-mediated dilation in arm and leg</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Blood flow</measure>
    <time_frame>Blood flow response during insulin clamp will be measured at baseline and at 8 weeks following intervention</time_frame>
    <description>Blood flow response during insulin clamp</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Insulin resistance</measure>
    <time_frame>Glucose disposal rate during insulin clamp will be measured at baseline and at 8 weeks following intervention</time_frame>
    <description>Glucose disposal rate during insulin clamp</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">45</enrollment>
  <condition>Type 2 Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Walking intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The walking program will consist of 45 minutes of walking (at a moderate pace) 5 days per week for 8 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Subjects will be instructed to continue their usual lifestyle for 8 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Unilateral leg heating</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This intervention consists of 45 minutes of unilateral leg heating (40-42 degree C) 5 days per week for 8 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Walking</intervention_name>
    <description>The walking program will consist of 45 minutes of walking (at a moderate pace) 5 days per week for 8 weeks.</description>
    <arm_group_label>Walking intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Unilateral leg heating</intervention_name>
    <description>This intervention consists of 45 minutes of unilateral leg heating (40-42 degree C) 5 days per week for 8 weeks.</description>
    <arm_group_label>Unilateral leg heating</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patients with type 2 diabetes who are overweight and obese (BMI 25-39 kg/m2) and sedentary
        (&lt;60 minutes structured exercise/week)

        Exclusion Criteria:

          1. Cardiovascular disease including myocardial infraction, heart failure, coronary artery
             disease, stroke;

          2. renal or hepatic diseases;

          3. active cancer;

          4. autoimmune diseases;

          5. immunosuppressant therapy;

          6. excessive alcohol consumption (&gt; 14 drinks/week);

          7. current tobacco use;

          8. pregnancy;

          9. mobility limitations.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jaume Padilla, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Missouri-Columbia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jaume Padilla, PhD</last_name>
    <phone>812 3453566</phone>
    <email>padillaja@missouri.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Missouri</name>
      <address>
        <city>Columbia</city>
        <state>Missouri</state>
        <zip>65212</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jaume Padilla</last_name>
      <phone>573-882-7056</phone>
      <email>padillaja@missouri.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 23, 2017</study_first_submitted>
  <study_first_submitted_qc>June 26, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 29, 2017</study_first_posted>
  <last_update_submitted>May 21, 2018</last_update_submitted>
  <last_update_submitted_qc>May 21, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 22, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Missouri-Columbia</investigator_affiliation>
    <investigator_full_name>Jaume Padilla</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

